Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring Hemodialysis
Public ClinicalTrials.gov record NCT00086164. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1/2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Pilot Trial to Assess the Effect of Treatment of the Recipient Vein of a Polytetrafluoroethylene (PTFE) Vascular Access Graft With Two Concentrations of E2F Decoy as Compared to Placebo on Neointimal Hyperplasia and the Preservation of Graft Function in Patients With Chronic Renal Failure Requiring Hemodialysis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the effect of recipient vein pretreatment of edifoligide (E2F Decoy), compared to placebo, on graft/recipient vein stenosis in polytetrafluoroethylene (PTFE) vascular access grafts placed for hemodialysis at 6 months after enrollment.
Study identification
- NCT ID
- NCT00086164
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 79 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2004 (Type not available)
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jul 19, 2005
Started 2004
United States locations
- U.S. sites
- 21
- U.S. states
- 12
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| National Institute of Clinical Research, American Medical Tower | Los Angeles | California | 90017 | — |
| Outcomes Research International, Inc. | Hudson | Florida | 34667 | — |
| University of Miami, School of Medicine | Miami | Florida | 33136 | — |
| Tampa General Hospital | Tampa | Florida | 33600 | — |
| LifeLink Transplant Institute | Tampa | Florida | 33606 | — |
| Emory University, Renal Division | Atlanta | Georgia | 30322 | — |
| University Transplant | Chicago | Illinois | 60612 | — |
| Stoney Island Dialysis | Chicago | Illinois | 60617 | — |
| Methodist Hospital, Tower Surgical | Indianapolis | Indiana | 46202 | — |
| Vascular Surgery Associates | Baton Rouge | Louisiana | 70808 | — |
| Tulane Center for Abdominal Transplant | New Orleans | Louisiana | 70112 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| Thoracic & Cardiovascular Healthcare Foundation | Lansing | Michigan | 48910 | — |
| St. Louis University, Division of Nephrology | St Louis | Missouri | 63110 | — |
| NYU Medical Center | New York | New York | 10016 | — |
| St. Luke's Hospital, Department of Surgery | New York | New York | 10025 | — |
| University of Rochester, The Center for Vascular Disease | Rochester | New York | 14642 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| Surgical Education | Greenville | South Carolina | 29605 | — |
| University of Utah School of Medicine, Dept of Surgery | Salt Lake City | Utah | 84132 | — |
| Nephrology Clinical Research Center | Charlottesville | Virginia | 22908 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00086164, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 19, 2005 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00086164 live on ClinicalTrials.gov.